Comparison of intravitreal ranibizumab therapy with and without laser photocoagulation for diabetic macular edema.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs031180328

Enrollment

100

Registered

2019-03-18

Start date

2015-04-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic macular edema

Interventions

Assignment of subjects to Randomized to intravitreal ranibizumab therapy with and without laser photocoagulation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HbA1c under 10 % CRT over 300 micrometer BCVA over 0.1 Written informed consent

Exclusion criteria

Exclusion criteria: Posttreatment for diabetic macular edema within 3 months

Design outcomes

Primary

Measure	Time frame
Visual acuity	—

Secondary

Measure	Time frame
Visual acuity and number of treatments	—

Contacts

Public ContactShigehiko Kitano

Tokyo Women`s Medical University Hospital

ge2s-ktn@asahi-net.or.jp+81-3-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026